Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Itamar Medical Ltd (ITMR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014297
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Itamar Medical Ltd (Itamar Medical) is a medical device company that offers bio-medical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a diagnostic device which provides accurate screening, detection, and diagnosis of sleep apnea and sleep disorders. Itamar Medical conducts research and development of non-invasive medical equipment for diagnosis of several medical conditions such as cardiovascular disease and respiratory disorders. The company’s products find application in research centers, clinical institutions and pharmaceutical clinical phase studies. Itamar Medical is headquartered in Caesarea, Israel.

Itamar Medical Ltd (ITMR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Itamar Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Itamar Medical Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Viola Private Equity to Invest USD24 Million in Itamar Medical 11
Equity Offering 12
Itamar Medical Plans to Raise USD6 Million in Rights Offering of Shares 12
Itamar Medical to Raise USD24 Million in Private Placement of Shares 13
Asset Transactions 14
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 14
Itamar Medical Ltd – Key Competitors 15
Itamar Medical Ltd – Key Employees 16
Itamar Medical Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Itamar Medical Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Itamar Medical Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Itamar Medical Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Itamar Medical Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Viola Private Equity to Invest USD24 Million in Itamar Medical 11
Itamar Medical Plans to Raise USD6 Million in Rights Offering of Shares 12
Itamar Medical to Raise USD24 Million in Private Placement of Shares 13
Galmed Pharma Acquires EndoPAT Devices from Itamar Medical for USD0.7 Million 14
Itamar Medical Ltd, Key Competitors 15
Itamar Medical Ltd, Key Employees 16
Itamar Medical Ltd, Subsidiaries 17

★海外企業調査レポート[Itamar Medical Ltd (ITMR)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LifePoint Health Inc (LPNT):製薬・医療:M&Aディール及び事業提携情報
    Summary LifePoint Health Inc (LifePoint) is a healthcare service provider which operates community hospitals, physician practices, outpatient centers, post-acute facilities and regional health systems. The company along with its subsidiaries delivers a range of medical and surgical services to non-u …
  • KELAG-Karntner Elektrizitats-Aktiengesellschaft:企業の戦略的SWOT分析
    KELAG-Karntner Elektrizitats-Aktiengesellschaft - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Pancontinental Oil & Gas NL (PCL):企業の財務・戦略的SWOT分析
    Summary Pancontinental Oil & Gas NL (Pancontinental) is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of conventional oil and gas properties. The company offers projects such as Namibia Walvis Basin EL 0037, Kenya Lamu Basin L6, T …
  • Acome:企業の戦略・SWOT・財務情報
    Acome - Strategy, SWOT and Corporate Finance Report Summary Acome - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • Takeda Pharmaceutical Company Limited:企業のM&A・事業提携・投資動向
    Takeda Pharmaceutical Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Takeda Pharmaceutical Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Statewide Superannuation Pty Ltd:企業の戦略的SWOT分析
    Statewide Superannuation Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Clovis Oncology Inc (CLVS):医療機器:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Kyowa Kirin Co Ltd (4151):企業の財務・戦略的SWOT分析
    Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Thermo Fisher Scientific Inc.:企業の戦略・SWOT・財務情報
    Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report Summary Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • DHL Supply Chain:企業の戦略・SWOT・財務分析
    DHL Supply Chain - Strategy, SWOT and Corporate Finance Report Summary DHL Supply Chain - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Axelar AB-製薬・医療分野:企業M&A・提携分析
    Summary Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company develops AXL1717, a novel anti cancer compound that inhibits tumor growth and reduces tumor sizes of malignant cells such as prostate cancer, breast cancer, glioblastoma, sarcoma, …
  • Medrobotics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Nidec Corporation:企業の戦略・SWOT・財務分析
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • CLAAS KGaA mbH:企業の戦略的SWOT分析
    CLAAS KGaA mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • China Communications Services Corporation Ltd (552):企業の財務・戦略的SWOT分析
    China Communications Services Corporation Ltd (552) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s ke …
  • The PNC Financial Services Group Inc:戦略・SWOT・企業財務分析
    The PNC Financial Services Group Inc - Strategy, SWOT and Corporate Finance Report Summary The PNC Financial Services Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • ARMZ Uranium Holding Co:企業の戦略的SWOT分析
    ARMZ Uranium Holding Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Helix BioMedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Helix BioMedix Inc (Helix) is a dermatology and consumer skin care products company. It develops an extensive proprietary library of structurally diverse bioactive peptides for the applications in consumer skin care products and prescription products. Its peptides are used in cosmeceuticals, …
  • AOL Inc:企業の戦略的SWOT分析
    AOL Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆